scispace - formally typeset
S

Sandosh Padmanabhan

Researcher at University of Glasgow

Publications -  350
Citations -  25524

Sandosh Padmanabhan is an academic researcher from University of Glasgow. The author has contributed to research in topics: Genome-wide association study & Blood pressure. The author has an hindex of 78, co-authored 315 publications receiving 20471 citations. Previous affiliations of Sandosh Padmanabhan include University of Copenhagen & British Heart Foundation.

Papers
More filters
Journal ArticleDOI

Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries

Mary F. Feitosa, +299 more
- 18 Jun 2018 - 
TL;DR: In insights into the role of alcohol consumption in the genetic architecture of hypertension, a large two-stage investigation incorporating joint testing of main genetic effects and single nucleotide variant (SNV)-alcohol consumption interactions is conducted.
Journal ArticleDOI

Genetically Distinct Subsets within ANCA-Associated Vasculitis

TL;DR: This study confirms that the pathogenesis of ANCA-associated vasculitis has a genetic component, shows genetic distinctions between granulomatosis with polyang iitis and microscopic polyangiitis that are associated with ANCA specificity, and suggests that the response against the autoantigen proteinase 3 is a central pathogenic feature ofproteinase 3 ANCA -associated vasulitis.
Journal ArticleDOI

Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits.

Evangelos Evangelou, +341 more
- 17 Sep 2018 - 
TL;DR: In this article, the largest genetic association study of blood pressure traits (systolic, diastolic and pulse pressure) to date in over 1 million people of European ancestry was conducted.
Journal ArticleDOI

Mendelian randomization of blood lipids for coronary heart disease

Michael V. Holmes, +67 more
TL;DR: The genetic findings support a causal effect of triglycerides on CHD risk, but a causal role for HDL-C, though possible, remains less certain.